small-cell lung cancer vaccine (pentavalent,Memorial Sloan-Kettering)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namesmall-cell lung cancer vaccine (pentavalent,Memorial Sloan-Kettering)

Drug Alias NameKLH/OPT-821 pentavalent vaccine (Memorial Sloan-Kettering)GD2/Gd3/Globo H/Fucosyl GM1/polysialic acid vaccine (Memorial Sloan-Kettering)

ClassificationBiologics > Antigen > Tumor antigenVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsSmall Cell Lung Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesMemorial Sloan Kettering Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMemorial Sloan Kettering Cancer Center

Active IndicationsN/A

Inactive IndicationsSmall Cell Lung Carcinoma

Other Information

ATC CodeN/A